Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.

37,205

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,841

Class I recallsReasonable probability of serious health consequences

24,366

Class II recallsTemporary or medically reversible health consequences

2,892

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,073 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/gias-foods-inc-recalls-bettergoods-authentic-italian-lemon-alfredo-fettuccine-because-possible-0Published October 1, 2026

Most affected stateHawaii 200 recalls mention this state

State: VT ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated October 2, 2026 ET

Summary (Year to date)

1,714 recalls have been announced year to date.
Sep 2026 was 3% higher than the previous complete period (Aug 2026: 182).
The highest complete period was Jun 2026 (297).
Oct 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,366
Class I	9,841
Class III	2,892
Not Yet Classified	2

FDA Recall Terminated Historical recordClass II

Haloperidol Decanoate Injection, 100 mg/mL, For Intra Muscular Use Only, 1 mL single dose vials (NDC 67457-409-00) packaged in cartons of five (NDC 67457-409-13), Rx only, Manufactured in India for: Mylan Institutional LLC Rockford, IL 61103

by Mylan Institutional LLC

Reason: Lack of Assurance of Sterility; due to leaking vials
Published: April 1, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL) 25 x 5 mL Single Dose Vials, For Intravenous or Intramuscular Use, Preservative Free, Rx Only, Manufactured by: West-Ward Pharmaceuticals, Eatontown, NJ 07724, NDC 0641-6028-25.

by West-Ward Pharmaceutical Corporation

Reason: Failed Impurities/Degradation Specifications; 12 month stability testing.
Published: April 1, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Antacid Liquid Regular Strength Antacid & Anti-Gas (Aluminum hydroxide 200 mg, Magnesium hydroxide 200 mg, Simethicone 20 mg (in each 5 mL, 1 teaspoon), Mint flavor, 12 fl oz (355 mL) bottle, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0073-02, UPC 3 11917 15114 4.

by Tarmac Products, Inc.

Reason: Microbial Contamination of Non-Sterile Products: Lots failed microbiological testing at the 12-month time point.
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

5% DEXTROSE Injection, USP, 250 mL ADD-Vantage Unit bag (NDC 0409-7100-02), UPC (01)0030404097100026; packaged in 24 bags per case pack (NDC 0409-7100-02), UPC (01)30304097100027(30)01, Rx ONLY, Hospira, Inc., Lake Forest, IL 60045.

by Hospira Inc.

Reason: Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

RIFAMPIN for Injection,USP, 600 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc., Eatontown, NJ 07724 NDC 23155-340-31

by Heritage Pharmaceuticals, Inc.

Reason: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Colistimethate for Injection USP, 150 mg per vial, Rx Only, Manufactured by: Emcure Pharmaceuticals Ltd., Hinjwadi, Pune, India Manufactured for: Heritage Pharmaceuticals Inc. NDC 23155-193-31

by Heritage Pharmaceuticals, Inc.

Reason: Lack of Assurance of Sterility: Firm is recalling two injectable products due to concerns with quality control processes.
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ergoloid Mesylates ,1 mg tablets, 100 count bottle, Rx only, Manufactured by MUTUAL PHARMACEUTICAL CO., INC., PHILADELPHIA, PA 19124 USA for Sun Pharmaceutical Industries, Inc. 270 Prospect Plains Road, Cranbury, NJ 08512. NDC 53489-281-01

by Mutual Pharmaceutical Company, Inc.

Reason: Failed Impurities/Degradation Specifications: during long-term stability testing.
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10

by Mylan Institutional LLC

Reason: Subpotent Drug and Failed Impurities/Degradation Specifications
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

DOXOrubicin Hydrochloride Injection, USP, 200 mg/100 mL (2 mg/mL), For IV Use Only, Sterile, ISOTONIC SOLUTION, Caution: Cytotoxic Agent, 100 mL Multi-Dose Vial, Rx Only, Manufactured By: Onco Therapies Limited, Bangalore, 560105, INDIA, Distributed By: Amneal-Agila, LLC, Glasgow, KY, 42141, NDC 53150-317-01.

by Mylan Institutional LLC

Reason: Correct Labeled Product Mispack: Ifosfamide Injection 50 mg/mL, 60 mL, correctly labeled vial may have been mis-packaged in a carton labeled Doxorubicin Hydrochloride Injection 2 mg/mL, 100 mL
Published: March 25, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PROMETHAZINE DM SYRUP (Promethazine Hydrochloride, USP and Dextromethorphan Hydrobromide, USP), EACH 5 ml (ONE TEASPOONFUL) CONTAINS: Promethazine Hydrochloride 6.25 mg, Dextromethorphan Hydrobromide 15 mg, alcohol 7%, ONE PINT (574 mL), Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC: 0603-1586-58.

by Qualitest Pharmaceuticals

Reason: Presence of Foriegn Substance: Plastic cap closure particulates may be present in the product.
Published: March 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Simvastatin Tablets, USP, 80mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540 NDC 42571-080-90.

by Micro Labs Usa, Inc S

Reason: Failed Impurities/Degradation Specifications: Product failed a known impurity specification.
Published: March 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Simvastatin Tablets, USP, 40mg, Rx Only, 90 count bottles, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc., Princeton, NJ 08540 NDC 42571-0040-90.

by Micro Labs Usa, Inc S

Reason: Failed Impurities/Degradation Specifications: Product failed a known impurity specification.
Published: March 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Simvastatin Tablets, USP, 20mg a) 90- count bottle (42517-0020-10), b) 1000-count-bottle (NDC 42571-0020-10), Rx only, Manufactured by: Micro Labs Limited Goa-403 722, India, Manufactured for: Micro Labs USA Inc.,Princeton, NJ 08540

by Micro Labs Usa, Inc S

Reason: Failed Impurities/Degradation Specifications: Product failed a known impurity specification.
Published: March 18, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3561-15

by Actavis Inc

Reason: Subpotent Drug
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, in amber glass bottle with net fill weight of 16 g that provides 120 actuations, Rx only, Manufactured by HI-TECH PHARMACAL CO., INC. Amityville, NY 11701 for Akorn Inc. 1925 W. Field Court, Suite 300 Lake Forest Illinois, 60045. NDC 50383-700-16.

by Akorn, Inc.

Reason: Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride.
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxecta(TM) (oxycodone HCl) tablets, 7.5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-526-01

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxecta(TM) (oxycodone HCl) tablets, 5 mg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. Bristol, TN, NDC 60793-525-01

by Pfizer Inc.

Reason: Failed Impurities/Degradation Specifications
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Quinapril Tablets USP, 40 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 5026869115, NDC 50268-691-15

by AVKARE Inc.

Reason: Subpotent Drug
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Quinapril Tablets USP, 5 mg, Rx only, 50 tablets (5 X 10) unit dose pack, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, UPC 5026868815, NDC 50268-688-15

by AVKARE Inc.

Reason: Subpotent Drug
Published: March 11, 2015
Distribution: Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg per mL), Rx Only, 10 mL Multi-Dose Vial, For Intravenous Injection, Mfd. for: Sagent Pharmaceuticals, Schaumberg, IL 60195, NDC 25021-672-10

by Sagent Pharmaceuticals Inc

Reason: Lack of Assurance of Sterility: Recall initiated due to FDA observations pertaining to aseptic and GMP practices at the manufacturers site potentially impacting product sterility.
Published: March 11, 2015
Distribution: Nationwide

View recall →

Data last updated: October 2, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.